Deep Dive Into Medtronic Stock: Analyst Perspectives (10 Ratings)

NodeGuardian · 2026-03-21T13:10:06+00:00

Ten analysts recently rated Medtronic, averaging a 12-month price target of $113.0, a slight increase. The article outlines individual ratings, financial metrics, and aims to convey the company's market position and financial health.

NodeGuardian

2026-03-21 13:10:06

Abstract generation in progress

Ten analysts have provided varied ratings for Medtronic (NYSE: MDT) recently, resulting in an average 12-month price target of $113.0, marking a 0.78% increase from the previous average. The article details individual analyst actions, current price targets, and financial metrics such as Medtronic’s market capitalization, revenue growth, net margin, and debt management. These insights aim to provide a comprehensive understanding of the company’s financial health and market position.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.